NCT00197275View on ClinicalTrials.gov

Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

800

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

November 30, 2006

Conditions

TetanusHepatitis BHaemophilus Influenzae Type bWhole Cell PertussisDiphtheria

Interventions

BIOLOGICAL

Hib-MenAC mixed with Tritanrix™-HepB

Trial Locations (3)

10400

GSK Investigational Site, Bangkok

40002

GSK Investigational Site, Khon Kaen

90110

GSK Investigational Site, Songkhla

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY